EN DE
Watch Cryoport Inc for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Cryoport Inc (CYRX) fair value: what the stock is really worth

As of Nov 6, 2026: fair value (intrinsic value) of Cryoport Inc stock $4.22, price $19.10, that is 77.9% below the price, quality 53 out of 100. Rating: strongly overvalued. Calculated from audited financials with one of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Industrials US

CI Cryoport Inc logo Thin data Nov 8, 2026

Cryoport Inc

CYRX · US
Solid, but very expensive

Our calculation puts a fair price 78% below what the stock costs today.

Low debt
Quality 53/100
Expensive Growth (revenue 5y +47.0 %/yr in USD)
Loss over the last twelve months · -21.5% net margin (TTM) · fiscal year 2025 44.4%
Insiders sold $4.1M (6M)
Fair value $4.22 · Strongly overvalued (−77.9%)
Negative free cash flow
Trails peers (4/11)
Narrow moat 24/100
Thin data
⟳ CyclicalExcl. one-off gain
Watch Cryoport Inc for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$83.29 $4.70 Fair Value $4.22 Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 8, 2026.

How to read this chart

60‑month range $4.70 – $83.29 · fair‑value band $2.79 – $5.28 · the $19.10 price screens above the $4.22 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 8, 2026.

Follow Cryoport in your weekly email

Every Wednesday you see whether Cryoport is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide.

Show moreShow less

The company's Life Sciences Services segment provides temperature-controlled logistics and biostorage, bioservices and cryopreservation services within the life science industry.

Its Life Sciences Products segment manufactures, and sells cryogenic freezers, cryogenic dewars, and related ancillary accessories within the life science industry through direct sales or a distribution network.

The company's products include Cryoport Express Shippers; Cryoport Elite; Cryoport Express Cryogenic HV3 Shipping System; Smartpak Condition Monitoring System and Tec4Med, an IoT-based monitoring solutions; and Cryoport accessories.

It also provides Cryoport BioStorage/Bioservices, such as Cryoport Systems Bioservices, including controlled temperature storage, kitting, labelling, fulfillment, sample management, drug return, and Qualified Person drug product release.

In addition, the company offers IntegriCell services that comprise apheresis/leukapheresis collection, cryoshuttle transportation, cryo-process optimization, and cryopreservation services; Cryoport consulting services; MVE Fusion cryogenic system, a self-sustaining cryogenic freezer; and MVE Vario cryogenic system, a cryogenic freezer system.

Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services.

The company was founded in 1999 and is based in Brentwood, Tennessee.

Stock analysis

Cryoport Inc (CYRX) currently trades at $19.10, while our model-based Fair Value estimate is $4.22, 78% below the price, so the stock looks overvalued today.

Show more

Valuation

How firm this estimate is: it rests on 1 models at a data quality of 96/100, which puts the data coverage at low.

Scenario range: $2.79 (bear) to $5.28 (bull), the price of $19.10 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 53/100 (solid quality), in the Industrials sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Cryoport Inc reported revenue of $176M in FY2025 versus $223M in FY2021, a compound −5.7%/yr. Reported net income was $78.3M in FY2025.

Key figures

Market cap $963M Small · P/S ratio 5.03 · EPS (TTM) $−0.9000 · Net margin −21.5% · Return on equity −7.4% · Return on assets (EBIT) −5.6% (5-year average) · Operating margin −17.5% · Revenue (TTM) $192M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 24 out of 100 (medium confidence).

What moves the price

The share trades at its 52-week high and 147% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Industrials peers we cover trades at −36% fair-value upside, at −78%, CYRX screens richer than that median.

Fair Value models

Bear $2.79 Fair Value $4.22 Bull $5.28
Price $19.10 · Downside -77.9%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
NCAV (Graham) $2.79 $4.22 $5.28 54
All 1 models by family
Asset-Based
NCAV (Graham) $2.79 $4.22 $5.28 54

Open the full fair value analysis →

Quality Score breakdown

Overall quality 53/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 50
How much profit the company makes from its sales and capital
Quality Growth 59
Are margins and returns getting better?
Cashflow 0
Do the profits arrive as real cash?
Financial strength 75
Debt, balance sheet and risk of trouble
Investment 83
Does it invest with discipline instead of growing at any price?
Low Volatility 12
How calm the share price moves, does not count
Price momentum 91
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 100
Distance to the 52-week high, does not count
New shares 73
Buys back shares or issues new ones?

Open the full quality analysis →

Insider trades

In the last 6 months, 4 officers or directors sold shares worth $4.1M and none bought.

  • SaleJerrell SheltonPresident, CEO, Director3× since Mar 16, 2026: 39,612 shares, avg. $13.04$516,425Aug 11, 2026
  • SaleEdward J ZecchiniChief Digital and Tech Officer2× since Mar 16, 2026: 37,014 shares, avg. $14.15$523,626Jun 11, 2026
  • SaleRamkumar MandalamDirector2× since Dec 10, 2025: 34,784 shares, avg. $13.63$474,008Jun 8, 2026
  • SaleRobert StefanovichChief Financial Officer3× since Mar 12, 2026: 211,964 shares, avg. $14.57$3.1MJun 4, 2026
  • SaleMark W SawickiChief Scientific Officer2× since Mar 16, 2026: 4,576 shares, avg. $8.05$36,849Mar 23, 2026

Plus 5 other filings such as grants, option exercises or tax withholding. They are not market purchases or sales.

Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.

Source: SEC Form 4, as of Nov 6, 2026. All filings at the SEC ↗

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 58/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+1.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+47.0%
Revenue growth 21 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+45.9%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−38.1% (2020) → −20.9% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: no profitable base year
not computed

CYRX screens overvalued: fair value 78% below the price. Compare with United Parcel Service, Inc →

Compare Cryoport Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Integrated Freight & Logistics · 210 stocks

Beats the industry median on 4/10 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 53 · Above median
Fair Value upside −77.9% · Bottom 25%
Profitability
Return on assets 10.2% · Top 25%
Net margin (12 months) −21.5% · Bottom 25%
Operating margin (12 months) −17.5% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) 13.5% · Above median
Balance sheet
Debt / equity 0.00× · Lowest 25%

Valuation Multiplesvs Integrated Freight & Logistics median · lower = cheaper

P/B 1.92× · Pricier than median
P/S (12 months) 5.01× · Priciest 25%
PEG 62.13× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 47
FUTURE (revenue growth)68 · sector 45
PAST (return on equity)0 · sector 32
HEALTH (low debt)100 · sector 94
DIVIDEND (yield)0 · sector 64

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Integrated Freight & Logistics stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
S.F. Holding 002352 ¥34.54 ¥45.60 +32% vs CYRX
FedEx Corporation FDX $308.14 $350.86 +14% vs CYRX
United Parcel Service, Inc UPS $108.30 $107.24 −1% vs CYRX
Deutsche Post AG DHL €58.02 €53.62 −8% vs CYRX
Expeditors International of Washington, Inc EXPD $184.61 $117.46 −36% vs CYRX
Kuehne + Nagel International AG KNIN CHF 235.50 CHF 147.92 −37% vs CYRX
J.B. Hunt Transport Services, Inc JBHT $217.55 $133.78 −39% vs CYRX
Poste Italiane S.p.A PST €24.52 €14.76 −40% vs CYRX
DSV A/S DSV kr 1,470 kr 711.95 −52% vs CYRX
FedEx Freight Holding FDXF $123.56 $54.55 −56% vs CYRX

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Evidence & backtest34 years, failed companies included Financial calculatorsDCF, Graham, PEG and more
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cryoport Inc: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Cryoport Inc Fair Value". https://www.fairvalue-calculator.com/stock/CYRX

Frequently asked questions

Is Cryoport Inc (CYRX) overvalued or undervalued?
As of Nov 8, 2026, our model estimates a fair value of $4.22 versus a price of $19.10, about 78% lower (overvalued).
What is the fair value of CYRX?
Our model-based fair value for Cryoport Inc is $4.22 (as of Nov 8, 2026), built from audited fundamentals. The current price: $19.10.
What is the quality score of CYRX?
Cryoport Inc has a Quality Score of 53/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Cryoport Inc (CYRX)?
Our model-based price target is the fair value of $4.22 (as of Nov 8, 2026) from 1 valuation models. Cautious scenario $2.79, optimistic scenario $5.28. It is a calculation from audited fundamentals, not an analyst target.
What is the Cryoport Inc stock forecast for 2026?
Our models put fair value at $4.22, about 78% lower versus a price of $19.10 (overvalued). Cautious scenario $2.79, optimistic scenario $5.28. The calculation is refreshed regularly with new filings.
What is the revenue of Cryoport Inc (CYRX)?
Cryoport Inc reported trailing-twelve-month revenue of about $192M (latest available figure, as of Nov 8, 2026).
Does Cryoport Inc pay a dividend?
Cryoport Inc does not currently pay a dividend.
What is the intrinsic value of Cryoport Inc (CYRX)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Cryoport Inc it is $4.22 per share (as of Nov 8, 2026), against a price of $19.10. It is the blended result of 1 valuation models in 1 family (Asset-Based).
Is Cryoport Inc stock overvalued or undervalued in 2026?
As of Nov 8, 2026, CYRX trades above its calculated fair value: price $19.10, fair value $4.22, a gap of about −78% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of CYRX?
No. The price is what the market pays today ($19.10); the fair value is what the company's own numbers justify ($4.22). For Cryoport Inc the two are $14.88 per share apart. That gap is exactly why we show both numbers side by side.
How much is Cryoport Inc worth?
The market values Cryoport Inc at about $963M (market capitalisation, as of Nov 8, 2026). Per share that is $19.10; our models calculate a fair value of $4.22 per share.
What do the bullish and bearish scenarios say about CYRX?
Our models span a range for Cryoport Inc: cautious scenario $2.79, base $4.22, optimistic $5.28 per share (as of Nov 8, 2026, price $19.10). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the PEG ratio of CYRX?
The PEG ratio of Cryoport Inc is 62.13 (P/E divided by earnings growth, as of Nov 8, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of Cryoport Inc (CYRX)?
Balance-sheet figures for Cryoport Inc (as of Nov 8, 2026): return on equity −7.4%, debt of 0.00 per unit of equity. They feed the Quality Score of 53/100, which measures business quality independently of the share price.
How far is CYRX from its 52-week high?
Cryoport Inc trades at $19.10, at its 52-week high of $19.10 and 147% above the low of $7.72 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of $4.22 is for.
Which stocks are comparable to Cryoport Inc?
From the same area (Industrials) we also value United Parcel Service, Inc, FedEx Corporation, Deutsche Post AG, DSV A/S, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Cryoport Inc stock attractive at the current price?
The data as of Nov 8, 2026: price $19.10, calculated fair value $4.22 (−78%), Quality Score 53/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of CYRX calculated?
We run Cryoport Inc through 1 models from 1 family: Asset-Based. Every model gets the same audited fundamentals; the fair value of $4.22 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0% above its aggregate fair value. Cryoport Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Cryoport Inc (CYRX)?
The closing price on Nov 6, 2026 was $19.10. Our model-based fair value is $4.22, about 78% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Cryoport Inc right now?
The price sits above even our optimistic bull case ($5.28). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (53/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range ($2.79 to $5.28) leaves room in how you read the outcome.

Key figures of Cryoport Inc

How large is the market capitalisation of Cryoport Inc (CYRX)?
The market capitalisation of Cryoport Inc is $963M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Cryoport Inc (CYRX)?
The price-to-sales ratio of Cryoport Inc is 5.03 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Cryoport Inc (CYRX)?
Earnings per share at Cryoport Inc are $−0.9000. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Cryoport Inc (CYRX)?
The net margin of Cryoport Inc is −21.5% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Cryoport Inc (CYRX)?
The return on equity (ROE) of Cryoport Inc is −7.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Cryoport Inc (CYRX)?
On an EBIT basis the return on assets of Cryoport Inc is −5.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Cryoport Inc (CYRX)?
The operating margin of Cryoport Inc is −17.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Cryoport Inc (CYRX)?
Revenue at Cryoport Inc is growing +13.5% versus a year earlier (3y avg +1.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Cryoport Inc (CYRX) generate?
The free cash flow of Cryoport Inc is −$28.1M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Cryoport Inc (CYRX) hold?
Cryoport Inc holds more cash than debt, $19.8M net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Cryoport Inc in the live analysis

One click puts Cryoport Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.